- IBDEI0D6 ; ; 03-MAY-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,33057,1,3,0)
- ;;=3^Neopl,Unspec Behav,Right Kidney
- ;;^UTILITY(U,$J,358.3,33057,1,4,0)
- ;;=4^D49.511
- ;;^UTILITY(U,$J,358.3,33057,2)
- ;;=^5138160
- ;;^UTILITY(U,$J,358.3,33058,0)
- ;;=D49.512^^102^1377^9
- ;;^UTILITY(U,$J,358.3,33058,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33058,1,3,0)
- ;;=3^Neopl,Unspec Behav,Left Kidney
- ;;^UTILITY(U,$J,358.3,33058,1,4,0)
- ;;=4^D49.512
- ;;^UTILITY(U,$J,358.3,33058,2)
- ;;=^5138161
- ;;^UTILITY(U,$J,358.3,33059,0)
- ;;=Z48.22^^102^1377^2
- ;;^UTILITY(U,$J,358.3,33059,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33059,1,3,0)
- ;;=3^Aftercare Following Kidney Transplant
- ;;^UTILITY(U,$J,358.3,33059,1,4,0)
- ;;=4^Z48.22
- ;;^UTILITY(U,$J,358.3,33059,2)
- ;;=^5063039
- ;;^UTILITY(U,$J,358.3,33060,0)
- ;;=Z94.83^^102^1377^11
- ;;^UTILITY(U,$J,358.3,33060,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33060,1,3,0)
- ;;=3^Pancreas Transplant Status
- ;;^UTILITY(U,$J,358.3,33060,1,4,0)
- ;;=4^Z94.83
- ;;^UTILITY(U,$J,358.3,33060,2)
- ;;=^5063664
- ;;^UTILITY(U,$J,358.3,33061,0)
- ;;=B17.11^^102^1378^2
- ;;^UTILITY(U,$J,358.3,33061,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33061,1,3,0)
- ;;=3^Acute hepatitis C with hepatic coma
- ;;^UTILITY(U,$J,358.3,33061,1,4,0)
- ;;=4^B17.11
- ;;^UTILITY(U,$J,358.3,33061,2)
- ;;=^331777
- ;;^UTILITY(U,$J,358.3,33062,0)
- ;;=B18.2^^102^1378^10
- ;;^UTILITY(U,$J,358.3,33062,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33062,1,3,0)
- ;;=3^Chronic viral hepatitis C
- ;;^UTILITY(U,$J,358.3,33062,1,4,0)
- ;;=4^B18.2
- ;;^UTILITY(U,$J,358.3,33062,2)
- ;;=^5000548
- ;;^UTILITY(U,$J,358.3,33063,0)
- ;;=B17.10^^102^1378^3
- ;;^UTILITY(U,$J,358.3,33063,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33063,1,3,0)
- ;;=3^Acute hepatitis C without hepatic coma
- ;;^UTILITY(U,$J,358.3,33063,1,4,0)
- ;;=4^B17.10
- ;;^UTILITY(U,$J,358.3,33063,2)
- ;;=^5000542
- ;;^UTILITY(U,$J,358.3,33064,0)
- ;;=B19.20^^102^1378^24
- ;;^UTILITY(U,$J,358.3,33064,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33064,1,3,0)
- ;;=3^Viral hepatitis C without hepatic coma,Unspec
- ;;^UTILITY(U,$J,358.3,33064,1,4,0)
- ;;=4^B19.20
- ;;^UTILITY(U,$J,358.3,33064,2)
- ;;=^331436
- ;;^UTILITY(U,$J,358.3,33065,0)
- ;;=B19.21^^102^1378^23
- ;;^UTILITY(U,$J,358.3,33065,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33065,1,3,0)
- ;;=3^Viral hepatitis C with hepatic coma,Unspec
- ;;^UTILITY(U,$J,358.3,33065,1,4,0)
- ;;=4^B19.21
- ;;^UTILITY(U,$J,358.3,33065,2)
- ;;=^331437
- ;;^UTILITY(U,$J,358.3,33066,0)
- ;;=C22.0^^102^1378^16
- ;;^UTILITY(U,$J,358.3,33066,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33066,1,3,0)
- ;;=3^Liver cell carcinoma
- ;;^UTILITY(U,$J,358.3,33066,1,4,0)
- ;;=4^C22.0
- ;;^UTILITY(U,$J,358.3,33066,2)
- ;;=^5000933
- ;;^UTILITY(U,$J,358.3,33067,0)
- ;;=C22.7^^102^1378^8
- ;;^UTILITY(U,$J,358.3,33067,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33067,1,3,0)
- ;;=3^Carcinomas of liver NEC
- ;;^UTILITY(U,$J,358.3,33067,1,4,0)
- ;;=4^C22.7
- ;;^UTILITY(U,$J,358.3,33067,2)
- ;;=^5000938
- ;;^UTILITY(U,$J,358.3,33068,0)
- ;;=C22.8^^102^1378^19
- ;;^UTILITY(U,$J,358.3,33068,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33068,1,3,0)
- ;;=3^Malignant neoplasm of liver, primary
- ;;^UTILITY(U,$J,358.3,33068,1,4,0)
- ;;=4^C22.8
- ;;^UTILITY(U,$J,358.3,33068,2)
- ;;=^5000939
- ;;^UTILITY(U,$J,358.3,33069,0)
- ;;=C22.1^^102^1378^14
- ;;^UTILITY(U,$J,358.3,33069,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33069,1,3,0)
- ;;=3^Intrahepatic bile duct carcinoma
- ;;^UTILITY(U,$J,358.3,33069,1,4,0)
- ;;=4^C22.1
- ;;^UTILITY(U,$J,358.3,33069,2)
- ;;=^5000934
- ;;^UTILITY(U,$J,358.3,33070,0)
- ;;=C22.9^^102^1378^18
- ;;^UTILITY(U,$J,358.3,33070,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33070,1,3,0)
- ;;=3^Malignant neoplasm of liver
- ;;^UTILITY(U,$J,358.3,33070,1,4,0)
- ;;=4^C22.9
- ;;^UTILITY(U,$J,358.3,33070,2)
- ;;=^267096
- ;;^UTILITY(U,$J,358.3,33071,0)
- ;;=C78.7^^102^1378^22
- ;;^UTILITY(U,$J,358.3,33071,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33071,1,3,0)
- ;;=3^Secondary malig neoplasm of liver and intrahepatic bile duct
- ;;^UTILITY(U,$J,358.3,33071,1,4,0)
- ;;=4^C78.7
- ;;^UTILITY(U,$J,358.3,33071,2)
- ;;=^5001339
- ;;^UTILITY(U,$J,358.3,33072,0)
- ;;=K74.60^^102^1378^12
- ;;^UTILITY(U,$J,358.3,33072,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33072,1,3,0)
- ;;=3^Cirrhosis of liver,Unspec
- ;;^UTILITY(U,$J,358.3,33072,1,4,0)
- ;;=4^K74.60
- ;;^UTILITY(U,$J,358.3,33072,2)
- ;;=^5008822
- ;;^UTILITY(U,$J,358.3,33073,0)
- ;;=K76.0^^102^1378^13
- ;;^UTILITY(U,$J,358.3,33073,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33073,1,3,0)
- ;;=3^Fatty (change of) liver, not elsewhere classified
- ;;^UTILITY(U,$J,358.3,33073,1,4,0)
- ;;=4^K76.0
- ;;^UTILITY(U,$J,358.3,33073,2)
- ;;=^5008831
- ;;^UTILITY(U,$J,358.3,33074,0)
- ;;=K76.89^^102^1378^15
- ;;^UTILITY(U,$J,358.3,33074,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33074,1,3,0)
- ;;=3^Liver Disease NEC
- ;;^UTILITY(U,$J,358.3,33074,1,4,0)
- ;;=4^K76.89
- ;;^UTILITY(U,$J,358.3,33074,2)
- ;;=^5008835
- ;;^UTILITY(U,$J,358.3,33075,0)
- ;;=K70.30^^102^1378^6
- ;;^UTILITY(U,$J,358.3,33075,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33075,1,3,0)
- ;;=3^Alcoholic cirrhosis of liver without ascites
- ;;^UTILITY(U,$J,358.3,33075,1,4,0)
- ;;=4^K70.30
- ;;^UTILITY(U,$J,358.3,33075,2)
- ;;=^5008788
- ;;^UTILITY(U,$J,358.3,33076,0)
- ;;=K70.31^^102^1378^5
- ;;^UTILITY(U,$J,358.3,33076,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33076,1,3,0)
- ;;=3^Alcoholic cirrhosis of liver with ascites
- ;;^UTILITY(U,$J,358.3,33076,1,4,0)
- ;;=4^K70.31
- ;;^UTILITY(U,$J,358.3,33076,2)
- ;;=^5008789
- ;;^UTILITY(U,$J,358.3,33077,0)
- ;;=K75.4^^102^1378^7
- ;;^UTILITY(U,$J,358.3,33077,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33077,1,3,0)
- ;;=3^Autoimmune hepatitis
- ;;^UTILITY(U,$J,358.3,33077,1,4,0)
- ;;=4^K75.4
- ;;^UTILITY(U,$J,358.3,33077,2)
- ;;=^336610
- ;;^UTILITY(U,$J,358.3,33078,0)
- ;;=K74.69^^102^1378^11
- ;;^UTILITY(U,$J,358.3,33078,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33078,1,3,0)
- ;;=3^Cirrhosis of liver NEC
- ;;^UTILITY(U,$J,358.3,33078,1,4,0)
- ;;=4^K74.69
- ;;^UTILITY(U,$J,358.3,33078,2)
- ;;=^5008823
- ;;^UTILITY(U,$J,358.3,33079,0)
- ;;=K74.3^^102^1378^21
- ;;^UTILITY(U,$J,358.3,33079,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33079,1,3,0)
- ;;=3^Primary biliary cirrhosis
- ;;^UTILITY(U,$J,358.3,33079,1,4,0)
- ;;=4^K74.3
- ;;^UTILITY(U,$J,358.3,33079,2)
- ;;=^5008819
- ;;^UTILITY(U,$J,358.3,33080,0)
- ;;=K75.81^^102^1378^20
- ;;^UTILITY(U,$J,358.3,33080,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33080,1,3,0)
- ;;=3^Nonalcoholic steatohepatitis (NASH)
- ;;^UTILITY(U,$J,358.3,33080,1,4,0)
- ;;=4^K75.81
- ;;^UTILITY(U,$J,358.3,33080,2)
- ;;=K830^5008828
- ;;^UTILITY(U,$J,358.3,33081,0)
- ;;=B16.9^^102^1378^1
- ;;^UTILITY(U,$J,358.3,33081,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33081,1,3,0)
- ;;=3^Acute hepatitis B w/o delta-agent and without hepatic coma
- ;;^UTILITY(U,$J,358.3,33081,1,4,0)
- ;;=4^B16.9
- ;;^UTILITY(U,$J,358.3,33081,2)
- ;;=^5000540
- ;;^UTILITY(U,$J,358.3,33082,0)
- ;;=B18.1^^102^1378^9
- ;;^UTILITY(U,$J,358.3,33082,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33082,1,3,0)
- ;;=3^Chronic viral hepatitis B without delta-agent
- ;;^UTILITY(U,$J,358.3,33082,1,4,0)
- ;;=4^B18.1
- ;;^UTILITY(U,$J,358.3,33082,2)
- ;;=^5000547
- ;;^UTILITY(U,$J,358.3,33083,0)
- ;;=Z94.4^^102^1378^17
- ;;^UTILITY(U,$J,358.3,33083,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33083,1,3,0)
- ;;=3^Liver transplant status
- ;;^UTILITY(U,$J,358.3,33083,1,4,0)
- ;;=4^Z94.4
- ;;^UTILITY(U,$J,358.3,33083,2)
- ;;=^5063658
- ;;^UTILITY(U,$J,358.3,33084,0)
- ;;=Z48.23^^102^1378^4
- ;;^UTILITY(U,$J,358.3,33084,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33084,1,3,0)
- ;;=3^Aftercare Following Liver Transplant
- ;;^UTILITY(U,$J,358.3,33084,1,4,0)
- ;;=4^Z48.23
- ;;^UTILITY(U,$J,358.3,33084,2)
- ;;=^5063040
- ;;^UTILITY(U,$J,358.3,33085,0)
- ;;=J90.^^102^1379^16
- ;;^UTILITY(U,$J,358.3,33085,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33085,1,3,0)
- ;;=3^Pleural effusion, not elsewhere classified
- ;;^UTILITY(U,$J,358.3,33085,1,4,0)
- ;;=4^J90.
- ;;^UTILITY(U,$J,358.3,33085,2)
- ;;=^5008310
- ;;^UTILITY(U,$J,358.3,33086,0)
- ;;=C34.91^^102^1379^13
- ;;^UTILITY(U,$J,358.3,33086,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33086,1,3,0)
- ;;=3^Malignant neoplasm of unsp part of right bronchus or lung
- ;;^UTILITY(U,$J,358.3,33086,1,4,0)
- ;;=4^C34.91
- ;;^UTILITY(U,$J,358.3,33086,2)
- ;;=^5000967
- ;;^UTILITY(U,$J,358.3,33087,0)
- ;;=C34.92^^102^1379^12
- ;;^UTILITY(U,$J,358.3,33087,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33087,1,3,0)
- ;;=3^Malignant neoplasm of unsp part of left bronchus or lung
- ;;^UTILITY(U,$J,358.3,33087,1,4,0)
- ;;=4^C34.92
- ;;^UTILITY(U,$J,358.3,33087,2)
- ;;=^5000968
- ;;^UTILITY(U,$J,358.3,33088,0)
- ;;=C34.01^^102^1379^11
- ;;^UTILITY(U,$J,358.3,33088,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33088,1,3,0)
- ;;=3^Malignant neoplasm of right main bronchus
- ;;^UTILITY(U,$J,358.3,33088,1,4,0)
- ;;=4^C34.01
- ;;^UTILITY(U,$J,358.3,33088,2)
- ;;=^5000958
- ;;^UTILITY(U,$J,358.3,33089,0)
- ;;=C34.02^^102^1379^5
- ;;^UTILITY(U,$J,358.3,33089,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33089,1,3,0)
- ;;=3^Malignant neoplasm of left main bronchus
- ;;^UTILITY(U,$J,358.3,33089,1,4,0)
- ;;=4^C34.02
- ;;^UTILITY(U,$J,358.3,33089,2)
- ;;=^5000959
- ;;^UTILITY(U,$J,358.3,33090,0)
- ;;=C34.11^^102^1379^15
- ;;^UTILITY(U,$J,358.3,33090,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33090,1,3,0)
- ;;=3^Malignant neoplasm of upper lobe, right bronchus or lung
- ;;^UTILITY(U,$J,358.3,33090,1,4,0)
- ;;=4^C34.11
- ;;^UTILITY(U,$J,358.3,33090,2)
- ;;=^5000961
- ;;^UTILITY(U,$J,358.3,33091,0)
- ;;=C34.12^^102^1379^14
- ;;^UTILITY(U,$J,358.3,33091,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33091,1,3,0)
- ;;=3^Malignant neoplasm of upper lobe, left bronchus or lung
- ;;^UTILITY(U,$J,358.3,33091,1,4,0)
- ;;=4^C34.12
- ;;^UTILITY(U,$J,358.3,33091,2)
- ;;=^5000962
- ;;^UTILITY(U,$J,358.3,33092,0)
- ;;=C34.2^^102^1379^8
- ;;^UTILITY(U,$J,358.3,33092,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33092,1,3,0)
- ;;=3^Malignant neoplasm of middle lobe, bronchus or lung
- ;;^UTILITY(U,$J,358.3,33092,1,4,0)
- ;;=4^C34.2
- ;;^UTILITY(U,$J,358.3,33092,2)
- ;;=^267137
- ;;^UTILITY(U,$J,358.3,33093,0)
- ;;=C34.31^^102^1379^7
- ;;^UTILITY(U,$J,358.3,33093,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33093,1,3,0)
- ;;=3^Malignant neoplasm of lower lobe, right bronchus or lung
- ;;^UTILITY(U,$J,358.3,33093,1,4,0)
- ;;=4^C34.31
- ;;^UTILITY(U,$J,358.3,33093,2)
- ;;=^5133321
- ;;^UTILITY(U,$J,358.3,33094,0)
- ;;=C34.32^^102^1379^6
- ;;^UTILITY(U,$J,358.3,33094,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33094,1,3,0)
- ;;=3^Malignant neoplasm of lower lobe, left bronchus or lung
- ;;^UTILITY(U,$J,358.3,33094,1,4,0)
- ;;=4^C34.32
- ;;^UTILITY(U,$J,358.3,33094,2)
- ;;=^5133322
- ;;^UTILITY(U,$J,358.3,33095,0)
- ;;=C34.81^^102^1379^10
- ;;^UTILITY(U,$J,358.3,33095,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33095,1,3,0)
- ;;=3^Malignant neoplasm of ovrlp sites of right bronchus and lung
- ;;^UTILITY(U,$J,358.3,33095,1,4,0)
- ;;=4^C34.81
- ;;^UTILITY(U,$J,358.3,33095,2)
- ;;=^5000964
- ;;^UTILITY(U,$J,358.3,33096,0)
- ;;=C34.82^^102^1379^9
- ;;^UTILITY(U,$J,358.3,33096,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33096,1,3,0)
- ;;=3^Malignant neoplasm of ovrlp sites of left bronchus and lung
- ;;^UTILITY(U,$J,358.3,33096,1,4,0)
- ;;=4^C34.82
- ;;^UTILITY(U,$J,358.3,33096,2)
- ;;=^5000965
- ;;^UTILITY(U,$J,358.3,33097,0)
- ;;=Z48.24^^102^1379^2
- ;;^UTILITY(U,$J,358.3,33097,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33097,1,3,0)
- ;;=3^Aftercare Following Lung Transplant
- ;;^UTILITY(U,$J,358.3,33097,1,4,0)
- ;;=4^Z48.24
- ;;^UTILITY(U,$J,358.3,33097,2)
- ;;=^5063041
- ;;^UTILITY(U,$J,358.3,33098,0)
- ;;=Z48.280^^102^1379^1
- ;;^UTILITY(U,$J,358.3,33098,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33098,1,3,0)
- ;;=3^Aftercare Following Heart & Lung Transplant
- ;;^UTILITY(U,$J,358.3,33098,1,4,0)
- ;;=4^Z48.280
- ;;^UTILITY(U,$J,358.3,33098,2)
- ;;=^5063042
- ;;^UTILITY(U,$J,358.3,33099,0)
- ;;=Z94.3^^102^1379^3
- ;;^UTILITY(U,$J,358.3,33099,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33099,1,3,0)
- ;;=3^Heart & Lungs Transplant Status
- ;;^UTILITY(U,$J,358.3,33099,1,4,0)
- ;;=4^Z94.3
- ;;^UTILITY(U,$J,358.3,33099,2)
- ;;=^5063657
- ;;^UTILITY(U,$J,358.3,33100,0)
- ;;=Z94.2^^102^1379^4
- ;;^UTILITY(U,$J,358.3,33100,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33100,1,3,0)
- ;;=3^Lung Transplant Status
- ;;^UTILITY(U,$J,358.3,33100,1,4,0)
- ;;=4^Z94.2
- ;;^UTILITY(U,$J,358.3,33100,2)
- ;;=^5063656
- ;;^UTILITY(U,$J,358.3,33101,0)
- ;;=C83.38^^102^1380^22
- ;;^UTILITY(U,$J,358.3,33101,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33101,1,3,0)
- ;;=3^Diffuse large B-cell lymphoma, lymph nodes of multiple sites
- ;;^UTILITY(U,$J,358.3,33101,1,4,0)
- ;;=4^C83.38
- ;;^UTILITY(U,$J,358.3,33101,2)
- ;;=^5001579
- ;;^UTILITY(U,$J,358.3,33102,0)
- ;;=C83.58^^102^1380^28
- ;;^UTILITY(U,$J,358.3,33102,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33102,1,3,0)
- ;;=3^Lymphoblastic (diffuse) lymphoma, lymph nodes mult site
- ;;^UTILITY(U,$J,358.3,33102,1,4,0)
- ;;=4^C83.58
- ;;^UTILITY(U,$J,358.3,33102,2)
- ;;=^5001589
- ;;^UTILITY(U,$J,358.3,33103,0)
- ;;=C83.78^^102^1380^15
- ;;^UTILITY(U,$J,358.3,33103,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33103,1,3,0)
- ;;=3^Burkitt lymphoma, lymph nodes of multiple sites
- ;;^UTILITY(U,$J,358.3,33103,1,4,0)
- ;;=4^C83.78
- ;;^UTILITY(U,$J,358.3,33103,2)
- ;;=^5001599
- ;;^UTILITY(U,$J,358.3,33104,0)
- ;;=C83.18^^102^1380^34
- ;;^UTILITY(U,$J,358.3,33104,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33104,1,3,0)
- ;;=3^Mantle cell lymphoma, lymph nodes of multiple sites
- ;;^UTILITY(U,$J,358.3,33104,1,4,0)
- ;;=4^C83.18
- ;;^UTILITY(U,$J,358.3,33104,2)
- ;;=^5001569
- ;;^UTILITY(U,$J,358.3,33105,0)
- ;;=C84.68^^102^1380^12
- ;;^UTILITY(U,$J,358.3,33105,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33105,1,3,0)
- ;;=3^Anaplastic large cell lymphoma, ALK-pos, nodes mult site
- ;;^UTILITY(U,$J,358.3,33105,1,4,0)
- ;;=4^C84.68
- ;;^UTILITY(U,$J,358.3,33105,2)
- ;;=^5001659
- ;;^UTILITY(U,$J,358.3,33106,0)
- ;;=C84.78^^102^1380^11
- ;;^UTILITY(U,$J,358.3,33106,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33106,1,3,0)
- ;;=3^Anaplastic large cell lymphoma, ALK-neg, nodes mult site
- ;;^UTILITY(U,$J,358.3,33106,1,4,0)
- ;;=4^C84.78
- ;;^UTILITY(U,$J,358.3,33106,2)
- ;;=^5001669
- ;;^UTILITY(U,$J,358.3,33107,0)
- ;;=C81.08^^102^1380^47
- ;;^UTILITY(U,$J,358.3,33107,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33107,1,3,0)
- ;;=3^Nodular lymphocyte predom Hodgkin lymphoma, nodes mult site
- ;;^UTILITY(U,$J,358.3,33107,1,4,0)
- ;;=4^C81.08
- ;;^UTILITY(U,$J,358.3,33107,2)
- ;;=^5001399
- ;;^UTILITY(U,$J,358.3,33108,0)
- ;;=C81.48^^102^1380^27
- ;;^UTILITY(U,$J,358.3,33108,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33108,1,3,0)
- ;;=3^Lymp-rich classical Hodgkin lymphoma, lymph nodes mult site
- ;;^UTILITY(U,$J,358.3,33108,1,4,0)
- ;;=4^C81.48
- ;;^UTILITY(U,$J,358.3,33108,2)
- ;;=^5001439
- ;;^UTILITY(U,$J,358.3,33109,0)
- ;;=C81.18^^102^1380^48
- ;;^UTILITY(U,$J,358.3,33109,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33109,1,3,0)
- ;;=3^Nodular sclerosis class Hodgkin lymphoma, nodes mult site
- ;;^UTILITY(U,$J,358.3,33109,1,4,0)
- ;;=4^C81.18
- ;;^UTILITY(U,$J,358.3,33109,2)
- ;;=^5001409
- ;;^UTILITY(U,$J,358.3,33110,0)
- ;;=C81.28^^102^1380^38
- ;;^UTILITY(U,$J,358.3,33110,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33110,1,3,0)
- ;;=3^Mixed cellular classical Hodgkin lymphoma, nodes mult site
- ;;^UTILITY(U,$J,358.3,33110,1,4,0)
- ;;=4^C81.28
- ;;^UTILITY(U,$J,358.3,33110,2)
- ;;=^5001419
- ;;^UTILITY(U,$J,358.3,33111,0)
- ;;=C81.38^^102^1380^29
- ;;^UTILITY(U,$J,358.3,33111,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33111,1,3,0)
- ;;=3^Lymphocy depleted class Hodgkin lymphoma, nodes mult site
- ;;^UTILITY(U,$J,358.3,33111,1,4,0)
- ;;=4^C81.38
- ;;^UTILITY(U,$J,358.3,33111,2)
- ;;=^5001429
- ;;^UTILITY(U,$J,358.3,33112,0)
- ;;=C82.98^^102^1380^25
- ;;^UTILITY(U,$J,358.3,33112,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33112,1,3,0)
- ;;=3^Follicular lymphoma, unsp, lymph nodes of multiple sites
- ;;^UTILITY(U,$J,358.3,33112,1,4,0)
- ;;=4^C82.98
- ;;^UTILITY(U,$J,358.3,33112,2)
- ;;=^5001549
- ;;^UTILITY(U,$J,358.3,33113,0)
- ;;=C84.08^^102^1380^44
- ;;^UTILITY(U,$J,358.3,33113,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33113,1,3,0)
- ;;=3^Mycosis fungoides, lymph nodes of multiple sites
- ;;^UTILITY(U,$J,358.3,33113,1,4,0)
- ;;=4^C84.08
- ;;^UTILITY(U,$J,358.3,33113,2)
- ;;=^5001629
- ;;^UTILITY(U,$J,358.3,33114,0)
- ;;=C84.18^^102^1380^53
- ;;^UTILITY(U,$J,358.3,33114,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33114,1,3,0)
- ;;=3^Sezary disease, lymph nodes of multiple sites
- ;;^UTILITY(U,$J,358.3,33114,1,4,0)
- ;;=4^C84.18
- ;;^UTILITY(U,$J,358.3,33114,2)
- ;;=^5001639
- ;;^UTILITY(U,$J,358.3,33115,0)
- ;;=C91.40^^102^1380^26
- ;;^UTILITY(U,$J,358.3,33115,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33115,1,3,0)
- ;;=3^Hairy cell leukemia not having achieved remission
- ;;^UTILITY(U,$J,358.3,33115,1,4,0)
- ;;=4^C91.40
- ;;^UTILITY(U,$J,358.3,33115,2)
- ;;=^5001771
- ;;^UTILITY(U,$J,358.3,33116,0)
- ;;=C96.0^^102^1380^41
- ;;^UTILITY(U,$J,358.3,33116,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33116,1,3,0)
- ;;=3^Multifocal and multisystemic Langerhans-cell histiocytosis
- ;;^UTILITY(U,$J,358.3,33116,1,4,0)
- ;;=4^C96.0
- ;;^UTILITY(U,$J,358.3,33116,2)
- ;;=^5001859
- ;;^UTILITY(U,$J,358.3,33117,0)
- ;;=C84.48^^102^1380^49
- ;;^UTILITY(U,$J,358.3,33117,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33117,1,3,0)
- ;;=3^Peripheral T-cell lymphoma, not classified, nodes mult site
- ;;^UTILITY(U,$J,358.3,33117,1,4,0)
- ;;=4^C84.48
- ;;^UTILITY(U,$J,358.3,33117,2)
- ;;=^5001649
- ;;^UTILITY(U,$J,358.3,33118,0)
- ;;=C90.01^^102^1380^43
- ;;^UTILITY(U,$J,358.3,33118,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33118,1,3,0)
- ;;=3^Multiple myeloma in remission
- ;;^UTILITY(U,$J,358.3,33118,1,4,0)
- ;;=4^C90.01
- ;;^UTILITY(U,$J,358.3,33118,2)
- ;;=^267515
- ;;^UTILITY(U,$J,358.3,33119,0)
- ;;=C90.02^^102^1380^42
- ;;^UTILITY(U,$J,358.3,33119,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33119,1,3,0)
- ;;=3^Multiple myeloma in relapse
- ;;^UTILITY(U,$J,358.3,33119,1,4,0)
- ;;=4^C90.02
- ;;^UTILITY(U,$J,358.3,33119,2)
- ;;=^5001753
- ;;^UTILITY(U,$J,358.3,33120,0)
- ;;=C90.11^^102^1380^51
- ;;^UTILITY(U,$J,358.3,33120,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33120,1,3,0)
- ;;=3^Plasma cell leukemia in remission
- ;;^UTILITY(U,$J,358.3,33120,1,4,0)
- ;;=4^C90.11
- ;;^UTILITY(U,$J,358.3,33120,2)
- ;;=^267517
- ;;^UTILITY(U,$J,358.3,33121,0)
- ;;=C90.12^^102^1380^50
- ;;^UTILITY(U,$J,358.3,33121,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33121,1,3,0)
- ;;=3^Plasma cell leukemia in relapse
- ;;^UTILITY(U,$J,358.3,33121,1,4,0)
- ;;=4^C90.12
- ;;^UTILITY(U,$J,358.3,33121,2)
- ;;=^5001755
- ;;^UTILITY(U,$J,358.3,33122,0)
- ;;=C90.21^^102^1380^24
- ;;^UTILITY(U,$J,358.3,33122,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,33122,1,3,0)
- ;;=3^Extramedullary plasmacytoma in remission
- ;;^UTILITY(U,$J,358.3,33122,1,4,0)
- ;;=4^C90.21
- ;;^UTILITY(U,$J,358.3,33122,2)
- ;;=^5001757
- ;;^UTILITY(U,$J,358.3,33123,0)
- ;;=C90.31^^102^1380^55
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0D6 19771 printed Feb 18, 2025@23:12:44 Page 2
- IBDEI0D6 ; ; 03-MAY-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,33057,1,3,0)
- +2 ;;=3^Neopl,Unspec Behav,Right Kidney
- +3 ;;^UTILITY(U,$J,358.3,33057,1,4,0)
- +4 ;;=4^D49.511
- +5 ;;^UTILITY(U,$J,358.3,33057,2)
- +6 ;;=^5138160
- +7 ;;^UTILITY(U,$J,358.3,33058,0)
- +8 ;;=D49.512^^102^1377^9
- +9 ;;^UTILITY(U,$J,358.3,33058,1,0)
- +10 ;;=^358.31IA^4^2
- +11 ;;^UTILITY(U,$J,358.3,33058,1,3,0)
- +12 ;;=3^Neopl,Unspec Behav,Left Kidney
- +13 ;;^UTILITY(U,$J,358.3,33058,1,4,0)
- +14 ;;=4^D49.512
- +15 ;;^UTILITY(U,$J,358.3,33058,2)
- +16 ;;=^5138161
- +17 ;;^UTILITY(U,$J,358.3,33059,0)
- +18 ;;=Z48.22^^102^1377^2
- +19 ;;^UTILITY(U,$J,358.3,33059,1,0)
- +20 ;;=^358.31IA^4^2
- +21 ;;^UTILITY(U,$J,358.3,33059,1,3,0)
- +22 ;;=3^Aftercare Following Kidney Transplant
- +23 ;;^UTILITY(U,$J,358.3,33059,1,4,0)
- +24 ;;=4^Z48.22
- +25 ;;^UTILITY(U,$J,358.3,33059,2)
- +26 ;;=^5063039
- +27 ;;^UTILITY(U,$J,358.3,33060,0)
- +28 ;;=Z94.83^^102^1377^11
- +29 ;;^UTILITY(U,$J,358.3,33060,1,0)
- +30 ;;=^358.31IA^4^2
- +31 ;;^UTILITY(U,$J,358.3,33060,1,3,0)
- +32 ;;=3^Pancreas Transplant Status
- +33 ;;^UTILITY(U,$J,358.3,33060,1,4,0)
- +34 ;;=4^Z94.83
- +35 ;;^UTILITY(U,$J,358.3,33060,2)
- +36 ;;=^5063664
- +37 ;;^UTILITY(U,$J,358.3,33061,0)
- +38 ;;=B17.11^^102^1378^2
- +39 ;;^UTILITY(U,$J,358.3,33061,1,0)
- +40 ;;=^358.31IA^4^2
- +41 ;;^UTILITY(U,$J,358.3,33061,1,3,0)
- +42 ;;=3^Acute hepatitis C with hepatic coma
- +43 ;;^UTILITY(U,$J,358.3,33061,1,4,0)
- +44 ;;=4^B17.11
- +45 ;;^UTILITY(U,$J,358.3,33061,2)
- +46 ;;=^331777
- +47 ;;^UTILITY(U,$J,358.3,33062,0)
- +48 ;;=B18.2^^102^1378^10
- +49 ;;^UTILITY(U,$J,358.3,33062,1,0)
- +50 ;;=^358.31IA^4^2
- +51 ;;^UTILITY(U,$J,358.3,33062,1,3,0)
- +52 ;;=3^Chronic viral hepatitis C
- +53 ;;^UTILITY(U,$J,358.3,33062,1,4,0)
- +54 ;;=4^B18.2
- +55 ;;^UTILITY(U,$J,358.3,33062,2)
- +56 ;;=^5000548
- +57 ;;^UTILITY(U,$J,358.3,33063,0)
- +58 ;;=B17.10^^102^1378^3
- +59 ;;^UTILITY(U,$J,358.3,33063,1,0)
- +60 ;;=^358.31IA^4^2
- +61 ;;^UTILITY(U,$J,358.3,33063,1,3,0)
- +62 ;;=3^Acute hepatitis C without hepatic coma
- +63 ;;^UTILITY(U,$J,358.3,33063,1,4,0)
- +64 ;;=4^B17.10
- +65 ;;^UTILITY(U,$J,358.3,33063,2)
- +66 ;;=^5000542
- +67 ;;^UTILITY(U,$J,358.3,33064,0)
- +68 ;;=B19.20^^102^1378^24
- +69 ;;^UTILITY(U,$J,358.3,33064,1,0)
- +70 ;;=^358.31IA^4^2
- +71 ;;^UTILITY(U,$J,358.3,33064,1,3,0)
- +72 ;;=3^Viral hepatitis C without hepatic coma,Unspec
- +73 ;;^UTILITY(U,$J,358.3,33064,1,4,0)
- +74 ;;=4^B19.20
- +75 ;;^UTILITY(U,$J,358.3,33064,2)
- +76 ;;=^331436
- +77 ;;^UTILITY(U,$J,358.3,33065,0)
- +78 ;;=B19.21^^102^1378^23
- +79 ;;^UTILITY(U,$J,358.3,33065,1,0)
- +80 ;;=^358.31IA^4^2
- +81 ;;^UTILITY(U,$J,358.3,33065,1,3,0)
- +82 ;;=3^Viral hepatitis C with hepatic coma,Unspec
- +83 ;;^UTILITY(U,$J,358.3,33065,1,4,0)
- +84 ;;=4^B19.21
- +85 ;;^UTILITY(U,$J,358.3,33065,2)
- +86 ;;=^331437
- +87 ;;^UTILITY(U,$J,358.3,33066,0)
- +88 ;;=C22.0^^102^1378^16
- +89 ;;^UTILITY(U,$J,358.3,33066,1,0)
- +90 ;;=^358.31IA^4^2
- +91 ;;^UTILITY(U,$J,358.3,33066,1,3,0)
- +92 ;;=3^Liver cell carcinoma
- +93 ;;^UTILITY(U,$J,358.3,33066,1,4,0)
- +94 ;;=4^C22.0
- +95 ;;^UTILITY(U,$J,358.3,33066,2)
- +96 ;;=^5000933
- +97 ;;^UTILITY(U,$J,358.3,33067,0)
- +98 ;;=C22.7^^102^1378^8
- +99 ;;^UTILITY(U,$J,358.3,33067,1,0)
- +100 ;;=^358.31IA^4^2
- +101 ;;^UTILITY(U,$J,358.3,33067,1,3,0)
- +102 ;;=3^Carcinomas of liver NEC
- +103 ;;^UTILITY(U,$J,358.3,33067,1,4,0)
- +104 ;;=4^C22.7
- +105 ;;^UTILITY(U,$J,358.3,33067,2)
- +106 ;;=^5000938
- +107 ;;^UTILITY(U,$J,358.3,33068,0)
- +108 ;;=C22.8^^102^1378^19
- +109 ;;^UTILITY(U,$J,358.3,33068,1,0)
- +110 ;;=^358.31IA^4^2
- +111 ;;^UTILITY(U,$J,358.3,33068,1,3,0)
- +112 ;;=3^Malignant neoplasm of liver, primary
- +113 ;;^UTILITY(U,$J,358.3,33068,1,4,0)
- +114 ;;=4^C22.8
- +115 ;;^UTILITY(U,$J,358.3,33068,2)
- +116 ;;=^5000939
- +117 ;;^UTILITY(U,$J,358.3,33069,0)
- +118 ;;=C22.1^^102^1378^14
- +119 ;;^UTILITY(U,$J,358.3,33069,1,0)
- +120 ;;=^358.31IA^4^2
- +121 ;;^UTILITY(U,$J,358.3,33069,1,3,0)
- +122 ;;=3^Intrahepatic bile duct carcinoma
- +123 ;;^UTILITY(U,$J,358.3,33069,1,4,0)
- +124 ;;=4^C22.1
- +125 ;;^UTILITY(U,$J,358.3,33069,2)
- +126 ;;=^5000934
- +127 ;;^UTILITY(U,$J,358.3,33070,0)
- +128 ;;=C22.9^^102^1378^18
- +129 ;;^UTILITY(U,$J,358.3,33070,1,0)
- +130 ;;=^358.31IA^4^2
- +131 ;;^UTILITY(U,$J,358.3,33070,1,3,0)
- +132 ;;=3^Malignant neoplasm of liver
- +133 ;;^UTILITY(U,$J,358.3,33070,1,4,0)
- +134 ;;=4^C22.9
- +135 ;;^UTILITY(U,$J,358.3,33070,2)
- +136 ;;=^267096
- +137 ;;^UTILITY(U,$J,358.3,33071,0)
- +138 ;;=C78.7^^102^1378^22
- +139 ;;^UTILITY(U,$J,358.3,33071,1,0)
- +140 ;;=^358.31IA^4^2
- +141 ;;^UTILITY(U,$J,358.3,33071,1,3,0)
- +142 ;;=3^Secondary malig neoplasm of liver and intrahepatic bile duct
- +143 ;;^UTILITY(U,$J,358.3,33071,1,4,0)
- +144 ;;=4^C78.7
- +145 ;;^UTILITY(U,$J,358.3,33071,2)
- +146 ;;=^5001339
- +147 ;;^UTILITY(U,$J,358.3,33072,0)
- +148 ;;=K74.60^^102^1378^12
- +149 ;;^UTILITY(U,$J,358.3,33072,1,0)
- +150 ;;=^358.31IA^4^2
- +151 ;;^UTILITY(U,$J,358.3,33072,1,3,0)
- +152 ;;=3^Cirrhosis of liver,Unspec
- +153 ;;^UTILITY(U,$J,358.3,33072,1,4,0)
- +154 ;;=4^K74.60
- +155 ;;^UTILITY(U,$J,358.3,33072,2)
- +156 ;;=^5008822
- +157 ;;^UTILITY(U,$J,358.3,33073,0)
- +158 ;;=K76.0^^102^1378^13
- +159 ;;^UTILITY(U,$J,358.3,33073,1,0)
- +160 ;;=^358.31IA^4^2
- +161 ;;^UTILITY(U,$J,358.3,33073,1,3,0)
- +162 ;;=3^Fatty (change of) liver, not elsewhere classified
- +163 ;;^UTILITY(U,$J,358.3,33073,1,4,0)
- +164 ;;=4^K76.0
- +165 ;;^UTILITY(U,$J,358.3,33073,2)
- +166 ;;=^5008831
- +167 ;;^UTILITY(U,$J,358.3,33074,0)
- +168 ;;=K76.89^^102^1378^15
- +169 ;;^UTILITY(U,$J,358.3,33074,1,0)
- +170 ;;=^358.31IA^4^2
- +171 ;;^UTILITY(U,$J,358.3,33074,1,3,0)
- +172 ;;=3^Liver Disease NEC
- +173 ;;^UTILITY(U,$J,358.3,33074,1,4,0)
- +174 ;;=4^K76.89
- +175 ;;^UTILITY(U,$J,358.3,33074,2)
- +176 ;;=^5008835
- +177 ;;^UTILITY(U,$J,358.3,33075,0)
- +178 ;;=K70.30^^102^1378^6
- +179 ;;^UTILITY(U,$J,358.3,33075,1,0)
- +180 ;;=^358.31IA^4^2
- +181 ;;^UTILITY(U,$J,358.3,33075,1,3,0)
- +182 ;;=3^Alcoholic cirrhosis of liver without ascites
- +183 ;;^UTILITY(U,$J,358.3,33075,1,4,0)
- +184 ;;=4^K70.30
- +185 ;;^UTILITY(U,$J,358.3,33075,2)
- +186 ;;=^5008788
- +187 ;;^UTILITY(U,$J,358.3,33076,0)
- +188 ;;=K70.31^^102^1378^5
- +189 ;;^UTILITY(U,$J,358.3,33076,1,0)
- +190 ;;=^358.31IA^4^2
- +191 ;;^UTILITY(U,$J,358.3,33076,1,3,0)
- +192 ;;=3^Alcoholic cirrhosis of liver with ascites
- +193 ;;^UTILITY(U,$J,358.3,33076,1,4,0)
- +194 ;;=4^K70.31
- +195 ;;^UTILITY(U,$J,358.3,33076,2)
- +196 ;;=^5008789
- +197 ;;^UTILITY(U,$J,358.3,33077,0)
- +198 ;;=K75.4^^102^1378^7
- +199 ;;^UTILITY(U,$J,358.3,33077,1,0)
- +200 ;;=^358.31IA^4^2
- +201 ;;^UTILITY(U,$J,358.3,33077,1,3,0)
- +202 ;;=3^Autoimmune hepatitis
- +203 ;;^UTILITY(U,$J,358.3,33077,1,4,0)
- +204 ;;=4^K75.4
- +205 ;;^UTILITY(U,$J,358.3,33077,2)
- +206 ;;=^336610
- +207 ;;^UTILITY(U,$J,358.3,33078,0)
- +208 ;;=K74.69^^102^1378^11
- +209 ;;^UTILITY(U,$J,358.3,33078,1,0)
- +210 ;;=^358.31IA^4^2
- +211 ;;^UTILITY(U,$J,358.3,33078,1,3,0)
- +212 ;;=3^Cirrhosis of liver NEC
- +213 ;;^UTILITY(U,$J,358.3,33078,1,4,0)
- +214 ;;=4^K74.69
- +215 ;;^UTILITY(U,$J,358.3,33078,2)
- +216 ;;=^5008823
- +217 ;;^UTILITY(U,$J,358.3,33079,0)
- +218 ;;=K74.3^^102^1378^21
- +219 ;;^UTILITY(U,$J,358.3,33079,1,0)
- +220 ;;=^358.31IA^4^2
- +221 ;;^UTILITY(U,$J,358.3,33079,1,3,0)
- +222 ;;=3^Primary biliary cirrhosis
- +223 ;;^UTILITY(U,$J,358.3,33079,1,4,0)
- +224 ;;=4^K74.3
- +225 ;;^UTILITY(U,$J,358.3,33079,2)
- +226 ;;=^5008819
- +227 ;;^UTILITY(U,$J,358.3,33080,0)
- +228 ;;=K75.81^^102^1378^20
- +229 ;;^UTILITY(U,$J,358.3,33080,1,0)
- +230 ;;=^358.31IA^4^2
- +231 ;;^UTILITY(U,$J,358.3,33080,1,3,0)
- +232 ;;=3^Nonalcoholic steatohepatitis (NASH)
- +233 ;;^UTILITY(U,$J,358.3,33080,1,4,0)
- +234 ;;=4^K75.81
- +235 ;;^UTILITY(U,$J,358.3,33080,2)
- +236 ;;=K830^5008828
- +237 ;;^UTILITY(U,$J,358.3,33081,0)
- +238 ;;=B16.9^^102^1378^1
- +239 ;;^UTILITY(U,$J,358.3,33081,1,0)
- +240 ;;=^358.31IA^4^2
- +241 ;;^UTILITY(U,$J,358.3,33081,1,3,0)
- +242 ;;=3^Acute hepatitis B w/o delta-agent and without hepatic coma
- +243 ;;^UTILITY(U,$J,358.3,33081,1,4,0)
- +244 ;;=4^B16.9
- +245 ;;^UTILITY(U,$J,358.3,33081,2)
- +246 ;;=^5000540
- +247 ;;^UTILITY(U,$J,358.3,33082,0)
- +248 ;;=B18.1^^102^1378^9
- +249 ;;^UTILITY(U,$J,358.3,33082,1,0)
- +250 ;;=^358.31IA^4^2
- +251 ;;^UTILITY(U,$J,358.3,33082,1,3,0)
- +252 ;;=3^Chronic viral hepatitis B without delta-agent
- +253 ;;^UTILITY(U,$J,358.3,33082,1,4,0)
- +254 ;;=4^B18.1
- +255 ;;^UTILITY(U,$J,358.3,33082,2)
- +256 ;;=^5000547
- +257 ;;^UTILITY(U,$J,358.3,33083,0)
- +258 ;;=Z94.4^^102^1378^17
- +259 ;;^UTILITY(U,$J,358.3,33083,1,0)
- +260 ;;=^358.31IA^4^2
- +261 ;;^UTILITY(U,$J,358.3,33083,1,3,0)
- +262 ;;=3^Liver transplant status
- +263 ;;^UTILITY(U,$J,358.3,33083,1,4,0)
- +264 ;;=4^Z94.4
- +265 ;;^UTILITY(U,$J,358.3,33083,2)
- +266 ;;=^5063658
- +267 ;;^UTILITY(U,$J,358.3,33084,0)
- +268 ;;=Z48.23^^102^1378^4
- +269 ;;^UTILITY(U,$J,358.3,33084,1,0)
- +270 ;;=^358.31IA^4^2
- +271 ;;^UTILITY(U,$J,358.3,33084,1,3,0)
- +272 ;;=3^Aftercare Following Liver Transplant
- +273 ;;^UTILITY(U,$J,358.3,33084,1,4,0)
- +274 ;;=4^Z48.23
- +275 ;;^UTILITY(U,$J,358.3,33084,2)
- +276 ;;=^5063040
- +277 ;;^UTILITY(U,$J,358.3,33085,0)
- +278 ;;=J90.^^102^1379^16
- +279 ;;^UTILITY(U,$J,358.3,33085,1,0)
- +280 ;;=^358.31IA^4^2
- +281 ;;^UTILITY(U,$J,358.3,33085,1,3,0)
- +282 ;;=3^Pleural effusion, not elsewhere classified
- +283 ;;^UTILITY(U,$J,358.3,33085,1,4,0)
- +284 ;;=4^J90.
- +285 ;;^UTILITY(U,$J,358.3,33085,2)
- +286 ;;=^5008310
- +287 ;;^UTILITY(U,$J,358.3,33086,0)
- +288 ;;=C34.91^^102^1379^13
- +289 ;;^UTILITY(U,$J,358.3,33086,1,0)
- +290 ;;=^358.31IA^4^2
- +291 ;;^UTILITY(U,$J,358.3,33086,1,3,0)
- +292 ;;=3^Malignant neoplasm of unsp part of right bronchus or lung
- +293 ;;^UTILITY(U,$J,358.3,33086,1,4,0)
- +294 ;;=4^C34.91
- +295 ;;^UTILITY(U,$J,358.3,33086,2)
- +296 ;;=^5000967
- +297 ;;^UTILITY(U,$J,358.3,33087,0)
- +298 ;;=C34.92^^102^1379^12
- +299 ;;^UTILITY(U,$J,358.3,33087,1,0)
- +300 ;;=^358.31IA^4^2
- +301 ;;^UTILITY(U,$J,358.3,33087,1,3,0)
- +302 ;;=3^Malignant neoplasm of unsp part of left bronchus or lung
- +303 ;;^UTILITY(U,$J,358.3,33087,1,4,0)
- +304 ;;=4^C34.92
- +305 ;;^UTILITY(U,$J,358.3,33087,2)
- +306 ;;=^5000968
- +307 ;;^UTILITY(U,$J,358.3,33088,0)
- +308 ;;=C34.01^^102^1379^11
- +309 ;;^UTILITY(U,$J,358.3,33088,1,0)
- +310 ;;=^358.31IA^4^2
- +311 ;;^UTILITY(U,$J,358.3,33088,1,3,0)
- +312 ;;=3^Malignant neoplasm of right main bronchus
- +313 ;;^UTILITY(U,$J,358.3,33088,1,4,0)
- +314 ;;=4^C34.01
- +315 ;;^UTILITY(U,$J,358.3,33088,2)
- +316 ;;=^5000958
- +317 ;;^UTILITY(U,$J,358.3,33089,0)
- +318 ;;=C34.02^^102^1379^5
- +319 ;;^UTILITY(U,$J,358.3,33089,1,0)
- +320 ;;=^358.31IA^4^2
- +321 ;;^UTILITY(U,$J,358.3,33089,1,3,0)
- +322 ;;=3^Malignant neoplasm of left main bronchus
- +323 ;;^UTILITY(U,$J,358.3,33089,1,4,0)
- +324 ;;=4^C34.02
- +325 ;;^UTILITY(U,$J,358.3,33089,2)
- +326 ;;=^5000959
- +327 ;;^UTILITY(U,$J,358.3,33090,0)
- +328 ;;=C34.11^^102^1379^15
- +329 ;;^UTILITY(U,$J,358.3,33090,1,0)
- +330 ;;=^358.31IA^4^2
- +331 ;;^UTILITY(U,$J,358.3,33090,1,3,0)
- +332 ;;=3^Malignant neoplasm of upper lobe, right bronchus or lung
- +333 ;;^UTILITY(U,$J,358.3,33090,1,4,0)
- +334 ;;=4^C34.11
- +335 ;;^UTILITY(U,$J,358.3,33090,2)
- +336 ;;=^5000961
- +337 ;;^UTILITY(U,$J,358.3,33091,0)
- +338 ;;=C34.12^^102^1379^14
- +339 ;;^UTILITY(U,$J,358.3,33091,1,0)
- +340 ;;=^358.31IA^4^2
- +341 ;;^UTILITY(U,$J,358.3,33091,1,3,0)
- +342 ;;=3^Malignant neoplasm of upper lobe, left bronchus or lung
- +343 ;;^UTILITY(U,$J,358.3,33091,1,4,0)
- +344 ;;=4^C34.12
- +345 ;;^UTILITY(U,$J,358.3,33091,2)
- +346 ;;=^5000962
- +347 ;;^UTILITY(U,$J,358.3,33092,0)
- +348 ;;=C34.2^^102^1379^8
- +349 ;;^UTILITY(U,$J,358.3,33092,1,0)
- +350 ;;=^358.31IA^4^2
- +351 ;;^UTILITY(U,$J,358.3,33092,1,3,0)
- +352 ;;=3^Malignant neoplasm of middle lobe, bronchus or lung
- +353 ;;^UTILITY(U,$J,358.3,33092,1,4,0)
- +354 ;;=4^C34.2
- +355 ;;^UTILITY(U,$J,358.3,33092,2)
- +356 ;;=^267137
- +357 ;;^UTILITY(U,$J,358.3,33093,0)
- +358 ;;=C34.31^^102^1379^7
- +359 ;;^UTILITY(U,$J,358.3,33093,1,0)
- +360 ;;=^358.31IA^4^2
- +361 ;;^UTILITY(U,$J,358.3,33093,1,3,0)
- +362 ;;=3^Malignant neoplasm of lower lobe, right bronchus or lung
- +363 ;;^UTILITY(U,$J,358.3,33093,1,4,0)
- +364 ;;=4^C34.31
- +365 ;;^UTILITY(U,$J,358.3,33093,2)
- +366 ;;=^5133321
- +367 ;;^UTILITY(U,$J,358.3,33094,0)
- +368 ;;=C34.32^^102^1379^6
- +369 ;;^UTILITY(U,$J,358.3,33094,1,0)
- +370 ;;=^358.31IA^4^2
- +371 ;;^UTILITY(U,$J,358.3,33094,1,3,0)
- +372 ;;=3^Malignant neoplasm of lower lobe, left bronchus or lung
- +373 ;;^UTILITY(U,$J,358.3,33094,1,4,0)
- +374 ;;=4^C34.32
- +375 ;;^UTILITY(U,$J,358.3,33094,2)
- +376 ;;=^5133322
- +377 ;;^UTILITY(U,$J,358.3,33095,0)
- +378 ;;=C34.81^^102^1379^10
- +379 ;;^UTILITY(U,$J,358.3,33095,1,0)
- +380 ;;=^358.31IA^4^2
- +381 ;;^UTILITY(U,$J,358.3,33095,1,3,0)
- +382 ;;=3^Malignant neoplasm of ovrlp sites of right bronchus and lung
- +383 ;;^UTILITY(U,$J,358.3,33095,1,4,0)
- +384 ;;=4^C34.81
- +385 ;;^UTILITY(U,$J,358.3,33095,2)
- +386 ;;=^5000964
- +387 ;;^UTILITY(U,$J,358.3,33096,0)
- +388 ;;=C34.82^^102^1379^9
- +389 ;;^UTILITY(U,$J,358.3,33096,1,0)
- +390 ;;=^358.31IA^4^2
- +391 ;;^UTILITY(U,$J,358.3,33096,1,3,0)
- +392 ;;=3^Malignant neoplasm of ovrlp sites of left bronchus and lung
- +393 ;;^UTILITY(U,$J,358.3,33096,1,4,0)
- +394 ;;=4^C34.82
- +395 ;;^UTILITY(U,$J,358.3,33096,2)
- +396 ;;=^5000965
- +397 ;;^UTILITY(U,$J,358.3,33097,0)
- +398 ;;=Z48.24^^102^1379^2
- +399 ;;^UTILITY(U,$J,358.3,33097,1,0)
- +400 ;;=^358.31IA^4^2
- +401 ;;^UTILITY(U,$J,358.3,33097,1,3,0)
- +402 ;;=3^Aftercare Following Lung Transplant
- +403 ;;^UTILITY(U,$J,358.3,33097,1,4,0)
- +404 ;;=4^Z48.24
- +405 ;;^UTILITY(U,$J,358.3,33097,2)
- +406 ;;=^5063041
- +407 ;;^UTILITY(U,$J,358.3,33098,0)
- +408 ;;=Z48.280^^102^1379^1
- +409 ;;^UTILITY(U,$J,358.3,33098,1,0)
- +410 ;;=^358.31IA^4^2
- +411 ;;^UTILITY(U,$J,358.3,33098,1,3,0)
- +412 ;;=3^Aftercare Following Heart & Lung Transplant
- +413 ;;^UTILITY(U,$J,358.3,33098,1,4,0)
- +414 ;;=4^Z48.280
- +415 ;;^UTILITY(U,$J,358.3,33098,2)
- +416 ;;=^5063042
- +417 ;;^UTILITY(U,$J,358.3,33099,0)
- +418 ;;=Z94.3^^102^1379^3
- +419 ;;^UTILITY(U,$J,358.3,33099,1,0)
- +420 ;;=^358.31IA^4^2
- +421 ;;^UTILITY(U,$J,358.3,33099,1,3,0)
- +422 ;;=3^Heart & Lungs Transplant Status
- +423 ;;^UTILITY(U,$J,358.3,33099,1,4,0)
- +424 ;;=4^Z94.3
- +425 ;;^UTILITY(U,$J,358.3,33099,2)
- +426 ;;=^5063657
- +427 ;;^UTILITY(U,$J,358.3,33100,0)
- +428 ;;=Z94.2^^102^1379^4
- +429 ;;^UTILITY(U,$J,358.3,33100,1,0)
- +430 ;;=^358.31IA^4^2
- +431 ;;^UTILITY(U,$J,358.3,33100,1,3,0)
- +432 ;;=3^Lung Transplant Status
- +433 ;;^UTILITY(U,$J,358.3,33100,1,4,0)
- +434 ;;=4^Z94.2
- +435 ;;^UTILITY(U,$J,358.3,33100,2)
- +436 ;;=^5063656
- +437 ;;^UTILITY(U,$J,358.3,33101,0)
- +438 ;;=C83.38^^102^1380^22
- +439 ;;^UTILITY(U,$J,358.3,33101,1,0)
- +440 ;;=^358.31IA^4^2
- +441 ;;^UTILITY(U,$J,358.3,33101,1,3,0)
- +442 ;;=3^Diffuse large B-cell lymphoma, lymph nodes of multiple sites
- +443 ;;^UTILITY(U,$J,358.3,33101,1,4,0)
- +444 ;;=4^C83.38
- +445 ;;^UTILITY(U,$J,358.3,33101,2)
- +446 ;;=^5001579
- +447 ;;^UTILITY(U,$J,358.3,33102,0)
- +448 ;;=C83.58^^102^1380^28
- +449 ;;^UTILITY(U,$J,358.3,33102,1,0)
- +450 ;;=^358.31IA^4^2
- +451 ;;^UTILITY(U,$J,358.3,33102,1,3,0)
- +452 ;;=3^Lymphoblastic (diffuse) lymphoma, lymph nodes mult site
- +453 ;;^UTILITY(U,$J,358.3,33102,1,4,0)
- +454 ;;=4^C83.58
- +455 ;;^UTILITY(U,$J,358.3,33102,2)
- +456 ;;=^5001589
- +457 ;;^UTILITY(U,$J,358.3,33103,0)
- +458 ;;=C83.78^^102^1380^15
- +459 ;;^UTILITY(U,$J,358.3,33103,1,0)
- +460 ;;=^358.31IA^4^2
- +461 ;;^UTILITY(U,$J,358.3,33103,1,3,0)
- +462 ;;=3^Burkitt lymphoma, lymph nodes of multiple sites
- +463 ;;^UTILITY(U,$J,358.3,33103,1,4,0)
- +464 ;;=4^C83.78
- +465 ;;^UTILITY(U,$J,358.3,33103,2)
- +466 ;;=^5001599
- +467 ;;^UTILITY(U,$J,358.3,33104,0)
- +468 ;;=C83.18^^102^1380^34
- +469 ;;^UTILITY(U,$J,358.3,33104,1,0)
- +470 ;;=^358.31IA^4^2
- +471 ;;^UTILITY(U,$J,358.3,33104,1,3,0)
- +472 ;;=3^Mantle cell lymphoma, lymph nodes of multiple sites
- +473 ;;^UTILITY(U,$J,358.3,33104,1,4,0)
- +474 ;;=4^C83.18
- +475 ;;^UTILITY(U,$J,358.3,33104,2)
- +476 ;;=^5001569
- +477 ;;^UTILITY(U,$J,358.3,33105,0)
- +478 ;;=C84.68^^102^1380^12
- +479 ;;^UTILITY(U,$J,358.3,33105,1,0)
- +480 ;;=^358.31IA^4^2
- +481 ;;^UTILITY(U,$J,358.3,33105,1,3,0)
- +482 ;;=3^Anaplastic large cell lymphoma, ALK-pos, nodes mult site
- +483 ;;^UTILITY(U,$J,358.3,33105,1,4,0)
- +484 ;;=4^C84.68
- +485 ;;^UTILITY(U,$J,358.3,33105,2)
- +486 ;;=^5001659
- +487 ;;^UTILITY(U,$J,358.3,33106,0)
- +488 ;;=C84.78^^102^1380^11
- +489 ;;^UTILITY(U,$J,358.3,33106,1,0)
- +490 ;;=^358.31IA^4^2
- +491 ;;^UTILITY(U,$J,358.3,33106,1,3,0)
- +492 ;;=3^Anaplastic large cell lymphoma, ALK-neg, nodes mult site
- +493 ;;^UTILITY(U,$J,358.3,33106,1,4,0)
- +494 ;;=4^C84.78
- +495 ;;^UTILITY(U,$J,358.3,33106,2)
- +496 ;;=^5001669
- +497 ;;^UTILITY(U,$J,358.3,33107,0)
- +498 ;;=C81.08^^102^1380^47
- +499 ;;^UTILITY(U,$J,358.3,33107,1,0)
- +500 ;;=^358.31IA^4^2
- +501 ;;^UTILITY(U,$J,358.3,33107,1,3,0)
- +502 ;;=3^Nodular lymphocyte predom Hodgkin lymphoma, nodes mult site
- +503 ;;^UTILITY(U,$J,358.3,33107,1,4,0)
- +504 ;;=4^C81.08
- +505 ;;^UTILITY(U,$J,358.3,33107,2)
- +506 ;;=^5001399
- +507 ;;^UTILITY(U,$J,358.3,33108,0)
- +508 ;;=C81.48^^102^1380^27
- +509 ;;^UTILITY(U,$J,358.3,33108,1,0)
- +510 ;;=^358.31IA^4^2
- +511 ;;^UTILITY(U,$J,358.3,33108,1,3,0)
- +512 ;;=3^Lymp-rich classical Hodgkin lymphoma, lymph nodes mult site
- +513 ;;^UTILITY(U,$J,358.3,33108,1,4,0)
- +514 ;;=4^C81.48
- +515 ;;^UTILITY(U,$J,358.3,33108,2)
- +516 ;;=^5001439
- +517 ;;^UTILITY(U,$J,358.3,33109,0)
- +518 ;;=C81.18^^102^1380^48
- +519 ;;^UTILITY(U,$J,358.3,33109,1,0)
- +520 ;;=^358.31IA^4^2
- +521 ;;^UTILITY(U,$J,358.3,33109,1,3,0)
- +522 ;;=3^Nodular sclerosis class Hodgkin lymphoma, nodes mult site
- +523 ;;^UTILITY(U,$J,358.3,33109,1,4,0)
- +524 ;;=4^C81.18
- +525 ;;^UTILITY(U,$J,358.3,33109,2)
- +526 ;;=^5001409
- +527 ;;^UTILITY(U,$J,358.3,33110,0)
- +528 ;;=C81.28^^102^1380^38
- +529 ;;^UTILITY(U,$J,358.3,33110,1,0)
- +530 ;;=^358.31IA^4^2
- +531 ;;^UTILITY(U,$J,358.3,33110,1,3,0)
- +532 ;;=3^Mixed cellular classical Hodgkin lymphoma, nodes mult site
- +533 ;;^UTILITY(U,$J,358.3,33110,1,4,0)
- +534 ;;=4^C81.28
- +535 ;;^UTILITY(U,$J,358.3,33110,2)
- +536 ;;=^5001419
- +537 ;;^UTILITY(U,$J,358.3,33111,0)
- +538 ;;=C81.38^^102^1380^29
- +539 ;;^UTILITY(U,$J,358.3,33111,1,0)
- +540 ;;=^358.31IA^4^2
- +541 ;;^UTILITY(U,$J,358.3,33111,1,3,0)
- +542 ;;=3^Lymphocy depleted class Hodgkin lymphoma, nodes mult site
- +543 ;;^UTILITY(U,$J,358.3,33111,1,4,0)
- +544 ;;=4^C81.38
- +545 ;;^UTILITY(U,$J,358.3,33111,2)
- +546 ;;=^5001429
- +547 ;;^UTILITY(U,$J,358.3,33112,0)
- +548 ;;=C82.98^^102^1380^25
- +549 ;;^UTILITY(U,$J,358.3,33112,1,0)
- +550 ;;=^358.31IA^4^2
- +551 ;;^UTILITY(U,$J,358.3,33112,1,3,0)
- +552 ;;=3^Follicular lymphoma, unsp, lymph nodes of multiple sites
- +553 ;;^UTILITY(U,$J,358.3,33112,1,4,0)
- +554 ;;=4^C82.98
- +555 ;;^UTILITY(U,$J,358.3,33112,2)
- +556 ;;=^5001549
- +557 ;;^UTILITY(U,$J,358.3,33113,0)
- +558 ;;=C84.08^^102^1380^44
- +559 ;;^UTILITY(U,$J,358.3,33113,1,0)
- +560 ;;=^358.31IA^4^2
- +561 ;;^UTILITY(U,$J,358.3,33113,1,3,0)
- +562 ;;=3^Mycosis fungoides, lymph nodes of multiple sites
- +563 ;;^UTILITY(U,$J,358.3,33113,1,4,0)
- +564 ;;=4^C84.08
- +565 ;;^UTILITY(U,$J,358.3,33113,2)
- +566 ;;=^5001629
- +567 ;;^UTILITY(U,$J,358.3,33114,0)
- +568 ;;=C84.18^^102^1380^53
- +569 ;;^UTILITY(U,$J,358.3,33114,1,0)
- +570 ;;=^358.31IA^4^2
- +571 ;;^UTILITY(U,$J,358.3,33114,1,3,0)
- +572 ;;=3^Sezary disease, lymph nodes of multiple sites
- +573 ;;^UTILITY(U,$J,358.3,33114,1,4,0)
- +574 ;;=4^C84.18
- +575 ;;^UTILITY(U,$J,358.3,33114,2)
- +576 ;;=^5001639
- +577 ;;^UTILITY(U,$J,358.3,33115,0)
- +578 ;;=C91.40^^102^1380^26
- +579 ;;^UTILITY(U,$J,358.3,33115,1,0)
- +580 ;;=^358.31IA^4^2
- +581 ;;^UTILITY(U,$J,358.3,33115,1,3,0)
- +582 ;;=3^Hairy cell leukemia not having achieved remission
- +583 ;;^UTILITY(U,$J,358.3,33115,1,4,0)
- +584 ;;=4^C91.40
- +585 ;;^UTILITY(U,$J,358.3,33115,2)
- +586 ;;=^5001771
- +587 ;;^UTILITY(U,$J,358.3,33116,0)
- +588 ;;=C96.0^^102^1380^41
- +589 ;;^UTILITY(U,$J,358.3,33116,1,0)
- +590 ;;=^358.31IA^4^2
- +591 ;;^UTILITY(U,$J,358.3,33116,1,3,0)
- +592 ;;=3^Multifocal and multisystemic Langerhans-cell histiocytosis
- +593 ;;^UTILITY(U,$J,358.3,33116,1,4,0)
- +594 ;;=4^C96.0
- +595 ;;^UTILITY(U,$J,358.3,33116,2)
- +596 ;;=^5001859
- +597 ;;^UTILITY(U,$J,358.3,33117,0)
- +598 ;;=C84.48^^102^1380^49
- +599 ;;^UTILITY(U,$J,358.3,33117,1,0)
- +600 ;;=^358.31IA^4^2
- +601 ;;^UTILITY(U,$J,358.3,33117,1,3,0)
- +602 ;;=3^Peripheral T-cell lymphoma, not classified, nodes mult site
- +603 ;;^UTILITY(U,$J,358.3,33117,1,4,0)
- +604 ;;=4^C84.48
- +605 ;;^UTILITY(U,$J,358.3,33117,2)
- +606 ;;=^5001649
- +607 ;;^UTILITY(U,$J,358.3,33118,0)
- +608 ;;=C90.01^^102^1380^43
- +609 ;;^UTILITY(U,$J,358.3,33118,1,0)
- +610 ;;=^358.31IA^4^2
- +611 ;;^UTILITY(U,$J,358.3,33118,1,3,0)
- +612 ;;=3^Multiple myeloma in remission
- +613 ;;^UTILITY(U,$J,358.3,33118,1,4,0)
- +614 ;;=4^C90.01
- +615 ;;^UTILITY(U,$J,358.3,33118,2)
- +616 ;;=^267515
- +617 ;;^UTILITY(U,$J,358.3,33119,0)
- +618 ;;=C90.02^^102^1380^42
- +619 ;;^UTILITY(U,$J,358.3,33119,1,0)
- +620 ;;=^358.31IA^4^2
- +621 ;;^UTILITY(U,$J,358.3,33119,1,3,0)
- +622 ;;=3^Multiple myeloma in relapse
- +623 ;;^UTILITY(U,$J,358.3,33119,1,4,0)
- +624 ;;=4^C90.02
- +625 ;;^UTILITY(U,$J,358.3,33119,2)
- +626 ;;=^5001753
- +627 ;;^UTILITY(U,$J,358.3,33120,0)
- +628 ;;=C90.11^^102^1380^51
- +629 ;;^UTILITY(U,$J,358.3,33120,1,0)
- +630 ;;=^358.31IA^4^2
- +631 ;;^UTILITY(U,$J,358.3,33120,1,3,0)
- +632 ;;=3^Plasma cell leukemia in remission
- +633 ;;^UTILITY(U,$J,358.3,33120,1,4,0)
- +634 ;;=4^C90.11
- +635 ;;^UTILITY(U,$J,358.3,33120,2)
- +636 ;;=^267517
- +637 ;;^UTILITY(U,$J,358.3,33121,0)
- +638 ;;=C90.12^^102^1380^50
- +639 ;;^UTILITY(U,$J,358.3,33121,1,0)
- +640 ;;=^358.31IA^4^2
- +641 ;;^UTILITY(U,$J,358.3,33121,1,3,0)
- +642 ;;=3^Plasma cell leukemia in relapse
- +643 ;;^UTILITY(U,$J,358.3,33121,1,4,0)
- +644 ;;=4^C90.12
- +645 ;;^UTILITY(U,$J,358.3,33121,2)
- +646 ;;=^5001755
- +647 ;;^UTILITY(U,$J,358.3,33122,0)
- +648 ;;=C90.21^^102^1380^24
- +649 ;;^UTILITY(U,$J,358.3,33122,1,0)
- +650 ;;=^358.31IA^4^2
- +651 ;;^UTILITY(U,$J,358.3,33122,1,3,0)
- +652 ;;=3^Extramedullary plasmacytoma in remission
- +653 ;;^UTILITY(U,$J,358.3,33122,1,4,0)
- +654 ;;=4^C90.21
- +655 ;;^UTILITY(U,$J,358.3,33122,2)
- +656 ;;=^5001757
- +657 ;;^UTILITY(U,$J,358.3,33123,0)
- +658 ;;=C90.31^^102^1380^55